Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT04685525
What this trial is testing

Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT

Who this might be right for
Autologous TransplantMyeloma
Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT06541860
What this trial is testing

DAratumumab and REvlimid REfractory MM

Who this might be right for
Multiple Myeloma
Fondazione IRCCS Policlinico San Matteo di Pavia 100
Testing effectiveness (Phase 2)Study completedNCT02034110
What this trial is testing

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Who this might be right for
Cancer
Novartis Pharmaceuticals 206
Not applicableLooking for participantsNCT06515262
What this trial is testing

Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Who this might be right for
Relapsed/Refractory Multiple Myeloma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 10
Not applicableUnknownNCT05964270
What this trial is testing

Telemonitoring Among Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Isala 150
Testing effectiveness (Phase 2)Study completedNCT01852799
What this trial is testing

PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT03567616
What this trial is testing

Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 8
Not applicableStudy completedNCT02917239
What this trial is testing

Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)

Who this might be right for
Multiple Myeloma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 100
Testing effectiveness (Phase 2)Ended earlyNCT00113919
What this trial is testing

UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Arkansas 14
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Testing effectiveness (Phase 2)Looking for participantsNCT06645678
What this trial is testing

Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
YOUNGIL KOH 75
Large-scale testing (Phase 3)Looking for participantsNCT06152575
What this trial is testing

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Who this might be right for
Multiple Myeloma
Pfizer 492
Testing effectiveness (Phase 2)WithdrawnNCT02114502
What this trial is testing

Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03340883
What this trial is testing

Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Chinook Therapeutics, Inc. 21
Testing effectiveness (Phase 2)Study completedNCT01526694
What this trial is testing

Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera di Bolzano 30
Testing effectiveness (Phase 2)Study completedNCT00396266
What this trial is testing

AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF

Who this might be right for
Multiple MyelomaLymphoma, Non-Hodgkin
Genzyme, a Sanofi Company 22
Early research (Phase 1)UnknownNCT04500431
What this trial is testing

Clinical Study to Evaluate the Safety and Feasibility of spCART-269 Injection in the Treatment of MM

Who this might be right for
Multiple Myeloma
Shanghai Tongji Hospital, Tongji University School of Medicine 10
Not applicableLooking for participantsNCT07649681
What this trial is testing

Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

Who this might be right for
Multiple Myeloma (MM)GI CancerTaste Disorder+2 more
Wuerzburg University Hospital 198
Not applicableNot Yet RecruitingNCT06720207
What this trial is testing

Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

Who this might be right for
Non Hodgkin's LymphomaMultiple Myeloma (MM)
Shanghai East Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT02906332
What this trial is testing

Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 12
Next Page